01—History
Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2026. Drag across the bars to change the range.
- $2.32B
1 older move runs past ±150% (largest +1117.3%); point at, tap or drag across the bars to read one.
02—Ledger
Revenue, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $2.32B | +7.0% | 10-K | |
| FY2025 | $2.17B | +18.5% | 10-K | |
| FY2023 | $1.83B | +13.6% | 10-K | |
| FY2022 | $1.61B | +12.3% | 10-K | |
| FY2021 | $1.43B | +48.3% | 10-K | |
| FY2020 | $967.8M | +13.3% | 10-K | |
| FY2018 | $853.8M | +88.7% | 10-K | |
| FY2017 | $452.5M | +1117.3% | 10-K | |
| FY2016 | $37.2M | 0.0%flat | 10-K | |
| FY2015 | $37.2M | +48.0% | 10-K | |
| FY2014 | $25.1M | −19.9% | 10-K | |
| FY2013 | $31.3M | −34.0% | 10-K | |
| FY2012 | $47.5M | −83.6% | 10-K | |
| FY2011 | $289.6M | +56.5% | 10-K | |
| FY2010 | $185.0M | +21.9% | 10-K | |
| FY2009 | $151.8M | — | 10-K |
03—Questions
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is Exelixis's current revenue?
Exelixis (EXEL) annual revenue for 2026 was $2.32B, a 6.98% increase from 2025. Exelixis revenue for the quarter ending October 2, 2026 was $658.7M.
What was Exelixis's revenue in 2025?
Exelixis annual revenue for 2025 was $2.17B, a 18.49% increase from 2023.
What was Exelixis's revenue in 2023?
Exelixis annual revenue for 2023 was $1.83B, a 13.60% increase from 2022.
What is Exelixis's 5-year revenue CAGR?
Exelixis revenue grew at a compound annual growth rate (CAGR) of 10.09% from FY2021 to FY2026, going from $1.43B to $2.32B over 5 years.
- Company
- Exelixis
- Ticker
- EXEL
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)